Brokers Opinions on: Flexion Therapeutics, Inc. (FLXN)

(NASDAQ:FLXN) was the main talking point of investors.

The price target set for the stock is $81.03 and this sets up an interesting set of potential movement for the stock, according to data from Finviz's Research.

FLXN has been the topic of several other research reports. The value of the total investment in Flexion Therapeutics, Inc. went from $15,000 to $57,000 increasing 280.0% since the last quarter. ValuEngine upgraded Flexion Therapeutics from a sell rating to a hold rating in a research note on Friday, September 1st. The average revenue per share growth rate of Flexion Therapeutics, Inc. during the past 12 months was 0 percent. Earnings surprises can have a huge impact on a company's stock price.

Analysts have given a mean recommendation of 1.70 on this stock (A rating of less than 2 means buy, "hold" within the 3 range, "sell" within the 4 range, and "strong sell" within the 5 range). The most optimistic analyst sees the stock reaching $44 while the most conventional has $37 target price.

Flexion Therapeutics (FLXN) opened at 27.17 on Tuesday. After the latest session, which saw the stock close at a price of $25.76, FLXN sits below its 52-week high. The company has a 50-day moving average price of $21.38 and a 200 day moving average price of $20.54.

(NASDAQ:FLXN)'s stock was 35.44%. During last 3 month period, -0.03% of total institutional ownership has changed in the company shares. Flexion Therapeutics, Inc. (FLXN) average trading volume of 2,257,920 during the past month is 216.01% above its average volume over the past year, indicating that investors have been more active than usual in the stock in recent times. Equities research analysts expect that Flexion Therapeutics will post ($3.78) EPS for the current year. "(FLXN) Given "Outperform" Rating at BMO Capital Markets" was first reported by BBNS and is the sole property of of BBNS. If you are accessing this piece on another domain, it was copied illegally and reposted in violation of USA & global copyright laws.

More news: Commerce Bancshares Inc. Q3 Earnings Advance 9%

The market capitalization of Flexion Therapeutics, at $819.84 Million. By watching how many shares are trading hands and looking for any changes in that activity, trading opportunities can be spotted along with a deeper understanding of the reliability of other indicators on the stock. Following the completion of the transaction, the chief financial officer now directly owns 10,777 shares of the company's stock, valued at approximately $247,871. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. In this case, shares are down -20.12% from $32.25, the 52-week high touched on October 06, 2017, and are keeping their losses at 36.44% for the past 12 months.

How has the stock performed recently?

EBITDA margin is an indicator of a company's operating profitability as a percentage of its overall revenue. Janney Montgomery Scott LLC boosted its stake in shares of Flexion Therapeutics by 32.4% during the second quarter. (FLXN)'s shares projecting a $36.67 target price. The ROIC 5 year average of Flexion Therapeutics, Inc.

ATR value of the company was 1.78 and Relative Strength Index (RSI) was 51.34. Wells Fargo & Company MN now owns 124,717 shares of the specialty pharmaceutical company's stock worth $3,356,000 after purchasing an additional 25,047 shares in the last quarter.

News articles about Flexion Therapeutics (NASDAQ:FLXN) have been trending somewhat positive this week, Alpha One reports. The Company is focused on the development and commercialization of therapies for the treatment of patients with musculoskeletal conditions, beginning with osteoarthritis (OA), a type of degenerative arthritis and post-operative pain. The Company's product candidate, FX006, is an injectable intra-articular, meaning in the joint, sustained-release treatment for patients with moderate to severe OA pain.

Like this



13 October 2017
Tim's 'T' celebration is a plane for Federation Internationale de Football Association
Federation Internationale de Football Association released a statement saying they will be looking into the incident. Players have been sanctioned by the governing body in the past for advertising unsanctioned brands during games.

13 October 2017
Technical Indicators under Review: Hewlett Packard Enterprise Company (HPE)
Hewlett Packard Enterprise Company's insider ownership stands at 0.1 percent, while its insider transaction is -76.53 percent. In terms of the coming quarter, the consensus estimates are $0.44 in earnings per share (EPS) and $13.33 billion in revenue.

13 October 2017
Foot Locker, Inc. (FL), Applied Materials, Inc. (AMAT)
Three research analysts have rated the stock with a hold rating and twenty-two have assigned a buy rating to the company's stock. The company was maintained on Monday, July 10 by DA Davidson. (NASDAQ:AMAT) on Wednesday, February 3 to "Conviction Buy" rating.

13 October 2017
Hydrogen-Powered Truck Begins Work at LA-Long Beach
News just in from Toyota Motor North America is that it has developed a hydrogen fuel cell system for heavy-duty trucks. Starting October 23, the truck will begin its new port hauling duties, traveling around 200 miles each day.

13 October 2017
Dutch team wins 3000km solar auto challenge
With teams from the United States to Malaysia, from India to South Africa, the World challenge is truly a global affair. The team is made up entirely of students from the Delft University of Technology who design, build and race the cars.

13 October 2017
San Antonio has dropped out of the running for Amazon's second headquarters
The online retail giant's search for a new home where it will employ up to 50,000 people has become a much-coveted prize for cities across the nation.

13 October 2017
Amy Jackson's look in '2.0' creates a stir
Bankrolled by A Subhaskaran's Lyca Productions, 2.0 is expected to be released world over on January 25 next year. Amy Jackson's first look in the much anticipated 2.0 is out and it has got fans all excited, to say the least.

13 October 2017
Hot Trending Stock: Encana Corporation (ECA)
The rating scale runs from 1 to 5 with 5 indicating a Strong Sell, 1 indicating a Strong Buy and 3 indicating a Hold. However, 12.17% over the last one month, 20.95% for the last quarter and year to date performance stands at -2.64%.

13 October 2017
OnePlus 5T release: Redesigned model launching next month?
If the OnePlus 5T does come with a 18:9 display which is rumoured to be 6-inches in size, this will mark a drastic design change. OnePlus hasn't officially confirmed the new handset yet, but another leak points towards an imminent launch.

13 October 2017
Russia's Rokot Carries Sentinel Satellite Into Orbit for Atmosphere Monitoring
The data transmitted by Sentinel-5p will also help scientists to further study the formation of holes in our planet's ozone layer, according to Reuters.